Education
About Us
Working with TipRanks
Follow Us
Japan Medical Dynamic Marketing, Inc. (JP:7600)
:7600
7600 Stock Chart & Stats
¥487.00
-¥2.00(-0.33%)
At close: 4:00 PM EST
¥487.00
-¥2.00(-0.33%)
Day’s Range― - ―
52-Week Range¥460.00 - ¥758.00
Previous CloseN/A
Volume41.50K
Average Volume (3M)89.74K
Market Cap
¥16.46B
Enterprise Value¥19.41B
Total Cash (Recent Filing)¥2.35B
Total Debt (Recent Filing)¥4.35B
Price to Earnings (P/E)14.8
Beta0.49
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.12%
Share Statistics
EPS (TTM)N/A
Shares Outstanding26,475,880
10 Day Avg. Volume96,020
30 Day Avg. Volume89,743
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.61
Price to Sales (P/S)0.60
P/FCF Ratio-29.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthA strong equity base and low leverage provide durable financial flexibility to fund R&D, capital expenditures, and absorb shocks without immediate refinancing. This conservative balance-sheet posture supports sustained investment capacity and lowers financing risk over the medium term.
Revenue PickupA notable revenue pickup from 2024 to 2025 indicates improving product adoption or market positioning in medical devices. Sustained top-line traction enhances fixed-cost absorption, supports scalable operations, and creates room to invest in product expansion and distribution over coming quarters.
Stable Gross MarginsRelatively stable gross margins imply consistent manufacturing efficiency or pricing power on core products. That stability preserves unit economics as sales scale and provides a foundation for potential operating margin recovery if SG&A and overhead are managed effectively.
Bears Say
Negative Net IncomeA negative net profit margin in 2025 shows core operations failed to generate accounting profits, which erodes retained earnings and equity over time. If losses persist across multiple quarters, the company may need external capital, constraining strategic initiatives and long-term reinvestment.
Negative Free Cash FlowTurning free cash flow negative reduces internally available liquidity to fund capex, working capital and dividends. Sustained negative FCF over several months could force debt raises or equity issuance, increasing financing costs or diluting shareholders and limiting strategic flexibility.
Declining Operating MarginsDeclining EBIT and EBITDA margins point to rising operational costs or weakening operating leverage. Without structural cost reductions or pricing improvements, margin compression will blunt the benefits of revenue growth and reduce long-term returns on invested capital and cash generation capacity.
Japan Medical Dynamic Marketing, Inc. News
7600 FAQ
What was Japan Medical Dynamic Marketing, Inc.’s price range in the past 12 months?
Japan Medical Dynamic Marketing, Inc. lowest stock price was ¥460.00 and its highest was ¥758.00 in the past 12 months.
What is Japan Medical Dynamic Marketing, Inc.’s market cap?
Japan Medical Dynamic Marketing, Inc.’s market cap is ¥16.46B.
When is Japan Medical Dynamic Marketing, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Japan Medical Dynamic Marketing, Inc.’s earnings last quarter?
Currently, no data Available
Is Japan Medical Dynamic Marketing, Inc. overvalued?
According to Wall Street analysts Japan Medical Dynamic Marketing, Inc.’s price is currently Overvalued.
Does Japan Medical Dynamic Marketing, Inc. pay dividends?
Japan Medical Dynamic Marketing, Inc. pays a Annually dividend of ¥15 which represents an annual dividend yield of 3.12%. See more information on Japan Medical Dynamic Marketing, Inc. dividends here
What is Japan Medical Dynamic Marketing, Inc.’s EPS estimate?
Japan Medical Dynamic Marketing, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Japan Medical Dynamic Marketing, Inc. have?
Japan Medical Dynamic Marketing, Inc. has 26,475,880 shares outstanding.
What happened to Japan Medical Dynamic Marketing, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Japan Medical Dynamic Marketing, Inc.?
Currently, no hedge funds are holding shares in JP:7600
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Japan Medical Dynamic Marketing, Inc.
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices for the use in spinal instability surgery; and artificial bone fillers for the treatment of bone fractures, tumors, and other defects. It offers its products to medical professionals and hospitals. The company was incorporated in 1973 and is headquartered in Tokyo, Japan.
Technical Analysis
3-D Matrix
―
Create Medic Co., Ltd.
―
Techno Medica Co., Ltd.
―
Colan Totte.Co.,Ltd.
―
Koken Ltd.
―
Options Prices
Currently, No data available
---